Award
Delivery Order #SPE2DR26F9WC5
Short-Term Delivery Order for Renflexis Vials to Support Healthcare
Buyer
Defense Logistics Agency
Award Amount
$55,747.81
Ceiling
$55,747.81
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26F9WC5
NAICS
424210
This is a definitive delivery order contract awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The contract involves the procurement of Renflexis 100 mg vials, a biosimilar medication used for various medical treatments. This delivery order is part of a larger, ongoing indefinite delivery indefinite quantity (IDIQ) contract focused on pharmaceutical supplies, thereby supporting the agency's ability to maintain an efficient and responsive healthcare supply chain. The scope of work entails the timely delivery of these specific biosimilar vials to fulfill immediate healthcare needs. The contract was competitively awarded under the parent IDIQ vehicle, which enables flexible and ongoing pharmaceutical procurement. The period of performance for this delivery order is a brief, focused timeframe in mid-March 2026, aligning with urgent or specific medical supply demands.
Description
4571166360!RENFLEXIS 100 MG VIALS